Miscellaneous Haematology Flashcards
Antiphospholipid syndrome
Acquired disorder characterised by a hypercoaguable state
May be a primary disorder or secondary to SLE
Causes a paradoxical rise in APTT
Features of antiphospholipid syndrome
Venous or atrial thrombosis
Recurrent foetal loss
Livedo reticularis
Thrombocytopenia
Prolonged APTT
Pre eclampsia, pulmonary HTN
Antibodies associated with AP syndrome
Lupus anticoagulant
Anticardiolipin antibodies
Anti beta 2 glycoprotein I antibodies
Management of AP syndrome
Primary (no previous thrombi)- low dose aspirin
Secondary- lifelong warfarin with INR 2-3 (if continued add low dose aspirin and raise to 3-4)
Management of AP syndrome in pregnancy
Low dose aspirin when pregnancy confirmed
LMWH when foetal heart detected (stop at 34 weeks)
Non haemolytic febrile reaction
Fever, chills
Slow/stop the transfusion, paracetamol, monitor
Minor allergic reaction
Pruritus, urticaria
Temporarily stop the infusion, antihistamine, monitor
Anaphylaxis
Patients with IgA deficiency who have anti IgA antibodies
Hypotension, dyspnoea, wheezing, angioedema
Stop transfusion, IM adrenaline, ABC support
Acute haemolytic reaction
Fever, abdominal pain, hypotension, dark urine (3 hours post-transfusion)
ABO incompatible blood (human error). IgM destruction of RBC’s
Stop, send blood for Coombs test, repeat cross matching, supportive care
Transfusion associated circulatory overload
Pulmonary oedema, HTN
Slow transfusion, IV loop diuretics and oxygen
NB- The normal central venous pressure (normal = 0- 6 mmHg) is less consistent with fluid overload.
Transfusion related acute lung injury
Hypoxia, pulmonary infiltrates on CXR, fever, hypotension
Stop, oxygen and supportive care
Irradiated blood products
Depleted of T lymphocytes
Avoid transfusion associated graft versus host disease
Immune thrombocytopenia purpura
Immune mediated reduction in platelet count
Kids- often following an infection or vaccination
Adults- more chronic condition
Megakaryocytes in the bone marrow
ITP Features
Petechiae
Purpura
Bleeding
Catastrophic bleeding is rare
Type II hypersensitivity reaction
NB- can have anaemia alongside it (esp. if someone is bleeding)
Management of ITP
Emergency treatment: life-threatening or organ threatening bleeding: Platelet transfusion, IV methylprednisolone and intravenous immunoglobulin
Otherwise, PO steroids
Thrombotic thrombocytopenia purpura
ADAMST13
Platelet clots form in vessels leaving blood unable to clot so liable to bleed
Features
-fever
-fluctuating neuro signs (microemboli)
-microangiopathic haemolytic anaemia
-thrombocytopenia
-renal failure
Causes of TTP
Post infection (urinary, GI)
Pregnancy
Drugs- ciclosporin, OCP, penicillin
Tumours
SLE
HIV
Disseminated intravascular coagulation
Dysregulation of coagulation and fibrinolysis, leading to widespread clotting and resultant bleeding
TF released
Causes of DIC
Sepsis
Trauma
Obstetric complications eg. Amniotic fluid embolism or HELLP syndrome
Malignancy
NB- manage with FFP and cryoprecipitate
Typical blood picture of DIC
Decreased platelets
Decreased fibrinogen
Increased PT and APTT
Increased fibrinogen degradation products
Schistocytes due to microangiopathic haemolytic anaemia
Management of TTP
Plasma exchange
Steroids
Rituximab
Heparin induced thrombocytopenia
Antibodies developed against platelets in response to heparin
Features diagnosis and management of HIT
Antibodies activate a hypercoaguable state causing thrombosis and break down platelets causing thrombocytopenia (also hyperkalaemia)- A PROTHROMBITIC STATE
Diagnosis- HIT antibodies in blood
Management- switch to a different AC (eg. a direct thrombin inhibitor such as argatroban)
Acute graft versus host disease (GVHD)
Within 100 days of transplantation
Painful maculopapular rash (progress to toxic epidermal necrosis)
Jaundice
Watery or bloody diarrhoea
N and v
Culture negative fever
Steroids
Chronic GVHD
100 days after transplantation
Can arise after cute disease or de novo
Scleroderma, vitiligo
Conjunctivitis, corneal ulcers, scleritis
Dysphagia, oral ulcers and lichenous changes
Obstructive or restrictive lung disease
IV steroids